The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

被引：0
|
作者：
Jolanta Krajewska
Aleksandra Kukulska
Ewa Paliczka-Cieślik
Daria Handkiewicz-Junak
Tomasz Gawlik
Tomasz Olczyk
Aleksandra Kropińska
Aleksander Skoczylas
Barbara Michalik
Barbara Jarząb
机构：
[1] M. Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology,
[2] Gliwice Branch,undefined
来源：
Thyroid Research | / 6卷 / Suppl 2期
关键词：
Meningitis; Thyroid Cancer; Tyrosine Kinase Inhibitor; Lymphopenia; Prospective Clinical Trial;
D O I：
10.1186/1756-6614-6-S2-A33
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
    Resteghini, C.
    Cavalieri, S.
    Galbiati, D.
    Granata, R.
    Alfieri, S.
    Bergamini, C.
    Bossi, P.
    Licitra, L.
    Locati, L. D.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 349 - 361
  • [2] Side effects of tyrosine kinase inhibitors in cancer treatment
    Mencinger, Marina
    ONKOLOGIJA, 2018, 22 (01) : 24 - 27
  • [3] Tumor Heterogeneity for Assessment of Response to Tyrosine Kinase Inhibitors in Patients with Thyroid Cancer
    Bundschuh, R. A.
    Hartl, J.
    Zsoter, N.
    Papp, L.
    Biko, J.
    Buck, A. K.
    Lapa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S240 - S240
  • [4] A retrospective single centre study exploring the efficacy of sequential tyrosine kinase inhibitors (TKI) in patients with hepatocellular cancer
    Roberts, Catherine
    Kaina, Phillipa
    Propper, David
    Diamantis, Nikolaos
    Delderfield, Rachael
    Karuri, Alice
    Reyes, Marilyn
    Nijjar, Rajinder
    Slater, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS Thyroid effects of tyrosine kinase inhibitors
    Illouz, Frederic
    Braun, Doreen
    Briet, Claire
    Schweizer, Ulrich
    Rodien, Patrice
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (03) : R91 - R99
  • [6] Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update
    Nervo, Alice
    Retta, Francesca
    Ragni, Alberto
    Piovesan, Alessandro
    Mella, Alberto
    Biancone, Luigi
    Manganaro, Marco
    Gallo, Marco
    Arvat, Emanuela
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
  • [7] TYROSINE KINASE INHIBITORS (TKI) FOR THE TREATMENT OF ADVANCED MEDULLARY THYROID CARCINOMA: A SYSTEMATIC REVIEW AND INDIRECT COMPARISON
    Kawalec, P.
    VALUE IN HEALTH, 2016, 19 (07) : A708 - A708
  • [8] Non-selective side effects of non-receptor tyrosine kinase inhibitors (TKI)
    Tauer, J. T.
    Hofbauer, L. C.
    Koenig, S.
    Suttorp, M.
    KLINISCHE PADIATRIE, 2011, 223 (03): : 193 - 193
  • [9] Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects
    Puliafito, Ivana
    Esposito, Francesca
    Prestifilippo, Angela
    Marchisotta, Stefania
    Sciacca, Dorotea
    Vitale, Maria Paola
    Giuffrida, Dario
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Comprehensive plasma genotyping reveals mutational signatures that confer resistance to tyrosine kinase inhibitors (TKI) in patients with advanced lung cancer
    Bharde, Atul
    Behel, Vichitra
    Bhonde, Mandar
    Bose, Chirantan
    Raut, Nirmal Vivek
    D'Souza, Alain
    Jadhav, Bhagwat
    Prajapati, Sangeeta
    Kad, Trupti
    Ratnaparkhi, Mrunal
    Joshi, Sujit Krishnarao
    Jadhav, Vikas Balasaheb Leelavati
    Hariramani, Kanchan
    Mobeen, Fauzul
    Vasudevan, Aravindan
    Uttarwar, Mohan
    Khandare, Jayant
    Prabhash, Kumar
    Shafi, Gowhar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345